Skip to main content
. 2017 Feb 9;7:42199. doi: 10.1038/srep42199

Figure 3. Correlations of AKR1B10 expression with early tumor recurrence and overall survival in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

Figure 3

(A) Among the total study population (n = 110), patients with high AKR1B10 expression had significantly higher disease-free survival (DFS) than those with low expression within 2 years after liver resection. (B) Among patients with BCLC stage A HCC (n = 67), DFS (within 2 years) was significantly higher among those with high AKR1B10 expression than among those with low expression. (C) Among patients with BCLC stage B or C HCC (n = 43), DFS (within 2 years) was not significantly higher among those with high AKR1B10 expression than among those with low expression. (D) Among the total study population, patients with high AKR1B10 expression had significantly higher overall survival than those with low expression.